EntangleBio Information

More than 500 million people live with complex diseases that no single genetic variant can explain. EntangleBio systematically finds the combinations of variants that matter, explains how they cause disease, and identifies where treatment can intervene. For pharma, this means better-defined patient groups, new therapeutic targets, and new indications for existing drugs. The platform runs quantum-inspired algorithms on classical hardware today, with a credible path to quantum advantage for larger networks and higher-order gene combinations. Our team combines network medicine pioneers from Harvard Medical School and the University of Vienna with biotech builders behind Scipher Medicine and Foodome. We are backed by K5 Global and Cleveland Clinic.